Best Nucleoside Metabolic Inhibitor for breast neoplasms
Top-rated pick: Tolak — pharmaranks score 72/100, the highest of the 6 Nucleoside Metabolic Inhibitor drugs used for breast neoplasms, ranked by our independent FDA recall-safety score. Compare them with all treatments for breast neoplasms or the full Nucleoside Metabolic Inhibitor class. Not medical advice — always consult a professional.
Quick answer: Of the 6 nucleoside metabolic inhibitor drugs we rate for breast neoplasms, all are available as lower-cost generics, and most are topical. Our ranking reflects each drug’s FDA recall-safety record — not clinical effectiveness for breast neoplasms; the right choice depends on your situation, so confirm it with your prescriber.
How nucleoside metabolic inhibitor work
Nucleoside metabolic inhibitors are fake DNA building blocks that fast-dividing cancer cells mistake for the real thing. Once inside, they get incorporated into the cell's DNA and also block enzymes such as ribonucleotide reductase, which together halt DNA copying and cause the cancer cell to die.
Other drug classes for breast neoplasms
Top nucleoside metabolic inhibitor for breast neoplasms: 1. Tolak · 2. Capecitabine · 3. Efudex
| # | Drug | Rating | Type | Form | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|
| 1 | 72/100 | Prescription | Topical | Generic | $1 | View → | |
| 2 | Not yet rated | Prescription | Tablet | Generic | $14 | View → | |
| 3 | Not yet rated | Prescription | Topical | Generic | $1 | View → | |
| 4 | Not yet rated | Prescription | Injectable | Generic | $1 | View → | |
| 5 | Not yet rated | Prescription | Topical | Generic | $1 | View → | |
| 6 | Not yet rated | Prescription | System | Generic | $600 | View → |
Full ranking · 6 drugs
tolak
PrescriptionFDA-sourced
Tolak (Fluorouracil) is a nucleoside metabolic inhibitor used to treat Breast Neoplasms, Basal Cell Carcinoma, Colonic Neoplasms, Head and Neck Neoplasms.
Pharmacy pays
From ~$0.60· 4 formscapecitabine
Boxed warningPrescriptionFDA-sourced
Capecitabine is a nucleoside metabolic inhibitor used to treat Breast Neoplasms, Colorectal Neoplasms.
Pharmacy pays
From ~$10.85/30· 2 formsefudex
PrescriptionFDA-sourced
Efudex (Fluorouracil) is a nucleoside metabolic inhibitor used to treat Breast Neoplasms, Basal Cell Carcinoma, Colonic Neoplasms, Head and Neck Neoplasms.
Pharmacy pays
From ~$0.60· 4 forms
favlyxa
Boxed warningPrescriptionFDA-sourced
Favlyxa (Fluorouracil) is a nucleoside metabolic inhibitor used to treat Breast Neoplasms, Basal Cell Carcinoma, Colonic Neoplasms, Head and Neck Neoplasms.
Pharmacy pays
From ~$0.60· 4 formsfluorouracil
Boxed warningPrescriptionFDA-sourced
Fluorouracil is a nucleoside metabolic inhibitor used to treat Breast Neoplasms, Basal Cell Carcinoma, Colonic Neoplasms, Head and Neck Neoplasms.
Pharmacy pays
From ~$0.60· 4 formsinlexzo
PrescriptionFDA-sourced
Inlexzo (Gemcitabine Hydrochloride) is a nucleoside metabolic inhibitor used to treat Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Ovarian Neoplasms, Pancreatic Ductal Carcinoma.
Pharmacy pays
~$599.88 /30
Save up to 98% in classFrequently asked
- What is the best nucleoside metabolic inhibitor for breast neoplasms?
- By our independent recall-safety rating — not an efficacy measure — tolak ranks highest among Nucleoside Metabolic Inhibitor drugs used for breast neoplasms. Always consult a professional.
- Which nucleoside metabolic inhibitor drugs treat breast neoplasms?
- pharmaranks lists 6 Nucleoside Metabolic Inhibitor products used for breast neoplasms, per NIH RxClass drug-classification data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.